Fig 1: The Arp2/3 complex does not localize to L. monocytogenes actin-rich membrane invaginations. (A) Mixed Jeg-3 cell assay showing LifeAct-eGFP (green) concentrated at bacterial membrane invaginations. Alexa Fluor 594-phalloidin (indicated as “Actin”; red) was used to visualize total F-actin (in both the protrusion-forming and invagination-forming cells) and NucBlue (blue) to visualize host DNA in addition to bacteria present within the invaginations. Bars, 5 μm and 1 μm (insets). (B to B’’) Line scan analysis of an L. monocytogenes membrane protrusion/invagination from samples stained with fluorescent phalloidin (indicated as “Actin”; red) to visualize total F-actin and NucBlue (blue) to confirm the presence of the bacteria at the structures. Intensity is shown in arbitrary units (A.U.). (B’) A heat map of the representative LifeAct signal from panel B (light yellow indicates the highest signal intensity). Bar, 1 μm. (B’’) A 1.5-μm line (white line) was drawn through the protrusion/invagination (see panel B). The total F-actin intensity (red) as well as the corresponding LifeAct intensity (green) was plotted. (C) Jeg-3 cells were infected with L. monocytogenes, fixed, and stained with p34/ArpC2 targeting antibodies (green), NucBlue (blue) to visualize host cell DNA and bacteria, and Alexa Fluor 594-phalloidin (red) to visualize F-actin. Insets shown are an enlargement of the boxed regions. Bars, 5 μm and 1 μm (inset). (C’ and C’’) Line scan analysis of the L. monocytogenes membrane protrusion/invagination from the merge inset in panel C. (C’) Enlargement of the inset shown in panel C. Bar, 1 μm. (C’’) A 1.5-μm line (white line) was drawn through the protrusion/invagination in panel C’, and the total F-actin intensity (red) as well as the corresponding p34/Arpc2 intensity (green) was plotted. (D) Mixed HeLa cell assay demonstrating that endogenous p34/ArpC2 (green) concentrates in the actin-rich core of bacterial membrane protrusions but not at membrane invaginations. The membrane invagination marker CD147-GFP (pseudo-colored red) is expressed solely in the membrane invagination-forming host cell. Samples were fixed and stained with NucBlue (blue) to visualize host DNA as well as any bacteria within the invaginations. Bars, 5 μm and 1 μm (inset). (D’ and D’’) Line scan analysis of the L. monocytogenes membrane protrusion/invagination from the merge inset in panel D. (D’) Enlargement of the inset in panel D. Bar, 1 μm. (D’’) A 1.5-μm line (white line) was drawn through the protrusion/invagination in panel D’, and the CD147-GFP intensity (red) as well as the corresponding p34/Arpc2 intensity (green) was plotted. (E) Mixed Jeg-3 cell assay demonstrating p34-Emerald (green) absence at L. monocytogenes membrane invaginations when expressed in the invagination-forming cells, Alexa Fluor 594-phalloidin (red) to visualize F-actin and NucBlue (blue) to visualize host DNA and bacteria within the invaginations. Bars, 5 μm or 1 μm (inset). (E’ and E’’) Line scan analysis of the L. monocytogenes membrane protrusion/invagination from the merge inset in panel E. (E’) Enlargement of the merge inset shown in panel E. Bar, 1 μm. (C’’) A 1.5-μm line (white line) was drawn through the protrusion/invagination in panel E’, and the total F-actin intensity (red) as well as the corresponding p34-Emerald intensity (green) was plotted. (F to F’’) The same as shown in panels E to E’’ but using HeLa cells in place of Jeg-3 cells. The white stars in the merge panels indicate the locations of the untransfected protrusion-forming host cells. All insets are enlargements of the boxed regions. Color intensities are enhanced in the insets to clearly visualize the labeled proteins. Solid arrowheads indicate the invagination, and open arrowheads indicate the spreading bacteria. Full arrows point to p34/ArpC2 present within the membrane protrusion actin-rich core.
Fig 2: Co-expression of Lewis y antigen and CD147 in ovarian cancer cells. Bands 1, 3, 5 and 7, RMG-I cells; 2, 4, 6, and 8, RMG-I-hFUT cells. (A) Cell lysates from RMG-I cells were immunoprecipitated with anti-CD147 antibody, then immunoblotted with anti-CD147 and anti-Lewis y antibodies. (B) Bands 1-6, CD147 levels in precipitation samples following the addition of 1 µg anti-CD147 antibody to 1,000 µg of protein. Bands 1 and 2, CD147 levels in equal cytoplasmic precipitation samples; bands 3 and 4, CD147 levels in equal membrane precipitation samples; bands 5 and 6, CD147 levels in total protein precipitation samples; bands 7 and 8, CD147 levels in 150 µg total protein precipitation samples. The samples of bands 1-4, 5/6, and 7/8 were fresh samples collected at different times, and the experiment was conducted immediately following sample collection. (C) Bands 1-6, levels of glycosylated CD147 following the addition of 1 µg CD147 antibody to 6,000 µg of protein. The samples of bands 1/2, 3/4, and 5/6 were transferred onto polyvinylidene difluoride membranes and the membranes were incubated with different primary antibodies. Bands 1 and 2, Lewis y antigen level; bands 3 and 4, Lewis × antigen level; bands 5 and 6, sLewis × antigen level. NOT, anti-IgG antibody (negative control).
Fig 3: Association between CD147 and Lewis y antigen expression and survival rates of patients with ovarian cancer. Kaplan-Meier survival analysis revealed that a (A) high expression of CD147 and (B) Lewis y, (C) late surgical stage and (D) lymph node metastasis were independent risk factors for overall survival. log-rank P=0.005, 0.005, 0.00023 and 0.00036, respectively. FIGO, International Federation of Gynecology and Obstetrics.
Fig 4: RSK2 inhibitor suppresses the DMBA/TPA-induced carcinogenesis through blocking MDSCs recruitment. A DMBA/TPA model was generated in EpiCD147-OE mice and treated with CX-F9 by intraperitoneal injection twice a week. Representative images of induced mouse models are shown at 16 weeks after stimulation. Scale bar = 1 cm. B-C Tumor volume (B) and numbers (C) were measured every week as described in the Materials and Methods. The tumor growth curves are shown as the mean tumor volume ± SD. The significance of differences was evaluated using one-way ANOVA. D-E The percentage of CD11b+Gr1+ MDSCs is reduced in CX-F9 treated mice. Skin lesions were subjected to flow cytometry as described in the Materials and Methods. The gating strategy (D) and bar charts of the percentage of CD11b+Gr1+ MDSCs (E) are shown. Data are presented as the mean ± SD. The significance of differences was evaluated using Student’s t-test. F CX-F9 inhibits c-fos expression in JB6 cells. Whole-cell lysates of JB6-Mock or JB6-CD147 cells stimulated with EGF and treated with/without CX-F9 were extracted and subjected to immunoblot analysis using indicated antibodies. GAPDH was used as loading control. G Schematic diagram of the role of CD147 in the malignant transformation of keratinocytes
Fig 5: Secreted MMP Levels by astrocytes 24 h after receiving EVs from glioblastoma cells. MMP2 and MMP9 levels in the medium of astrocytes recipient of EVs from T98G cells (n = 6) or U-118 MG cells (n = 3) was determined by zymography. MMP2 zymograms were developed for 20 h. The MMP9 has a higher molecular weight pro-form, and a lower molecular weight active form. Our comparisons for MMP9 used the active form which is the lower band. MMP9 zymograms were developed for 2 days to obtain active MMP9 signal for the T98G cell EV conditions, but were developed for 8 days with the U-118 MG cell EV conditions to obtain any detectable signal. This indicates that the active MMP9 levels were much lower in the medium of astrocytes receiving U-118 MG cell EVs. b MMP2 and Active MMP9 levels shown in a were quantified and displayed graphically. Significant differences between two comparisons are noted with letters. A green letter (e.g. “a”) indicates the condition being compared to the other conditions. c Immunoblot analysis of MAPK pathway signaling in astrocytes incubated with EVs from T98G cells for 24 h are presented. The T98G cells were either wild-type or knockout for CD147, and either non-irradiated (C) or irradiated (IR). The three pathways, ERK1/2, p38, and JNK, are activated by phosphorylation. Quantification of relative activation is presented as the ratio of the phosphorylated protein levels to total protein levels. The numbers in blue indicate the sample to which the other samples were normalized. As measured by changes in phosphorylation levels, ERK1/2 and p38 signaling were not significantly altered in the different conditions. However, JNK signaling was significantly increased in response to EVs from irradiated T98G cells, but this effect was blocked by CD147 knockout. d Graphical representation of active JNK signaling shown in c. The “*” indicates the irradiated scramble condition had significantly increased p-JNK/total JNK levels relative to the control and the irradiated CD147 knockdown. The ‘C’ label represents the 0 Gy control samples, and the ‘IR’ label is for samples receiving 8 Gy of ionizing radiation
Supplier Page from Abcam for Anti-CD147 antibody [MEM-M6/1]